HR. 1266In Committee
Combating Illicit Xylazine Act
Establishes federal controls targeting illicit xylazine by treating it as a regulated drug trafficking substance
Plain-English overview
What this bill does
Establishes federal controls targeting illicit xylazine by treating it as a regulated drug trafficking substance
Key points
- Establish xylazine controls
- Authorize drug trafficking regulation
Current status
Where it stands
Status
In Committee
Latest action
2025-02-12 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
undefinedCongressional oversightConsumer affairsCrime and Law EnforcementCriminal procedure and sentencingDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesLicensing and registrations